Publication | Closed Access

Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

MalariaCôte D'ivoirePediatricsSchistosomiasisOrodispersible TabletsSoil-transmitted HelminthiasisMedicineParasitology